ProCE Banner Activity

Interactive Decision Support Tool: Global MCL Expert Treatment Guidance

Tool

Get recommendations from 5 global experts on MCL for your specific patient case using this interactive decision support tool.

Released: August 29, 2023

Begin Activity

Share

Faculty

Olivier Hermine

Olivier Hermine, MD, PhD

Professor
Department of Hematology
Institut Imagine
Necker Hosptial
Paris, France

Marco Ladetto

Marco Ladetto, MD

Associate Professor
Dipartimento di Medicina Traslazionale
Università del Piemonte Orientale
Vercelli/Novara/Alessandria, Piedmont, Italy
Director of Hematology Oncology
SCDU Ematologia
AO SS Antonio E Biagio e Cesare Arrigo
Alessandria, Piedmont, Italy

Ana Marin-Niebla

Ana Marin-Niebla, MD, PhD

Medical Specialist in Onco-Hematology
Senior Consultant in Hematology
Department of Hematology
Hospital Universitario Vall d'Hebron
Barcelona, Spain

Guilherme Perini

Guilherme Perini, MD

Medical Hematologist
Department of Hematology
Hospital Israelita Albert Einstein
Sao Paulo, Brazil

Max Topp

Max Topp, MD

Professor
Head of Hematology
Department of Hematology
Universitätsklinikum Würzburg
Würzburg, Germany

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Faculty Disclosure

Primary Author

Olivier Hermine, MD, PhD

Professor
Department of Hematology
Institut Imagine
Necker Hosptial
Paris, France

Olivier Hermine, MD, PhD: consultant/advisor/speaker: Bristol Myers-Squibb, Inatherys; researcher: Blueprint, Kyte, Roche; stocks/stock options: AB Science.

Marco Ladetto, MD

Associate Professor
Dipartimento di Medicina Traslazionale
Università del Piemonte Orientale
Vercelli/Novara/Alessandria, Piedmont, Italy
Director of Hematology Oncology
SCDU Ematologia
AO SS Antonio E Biagio e Cesare Arrigo
Alessandria, Piedmont, Italy

Marco Ladetto, MD: consultant/advisor/speaker: AbbVie, ADC Therapeutics, Amgen, AstraZeneca, Eusapharma, Gentili, Gilead/Kite, Incyte, Johnson & Johnson, Jazz, Lilly, Regeneron, Roche.

Ana Marin-Niebla, MD, PhD

Medical Specialist in Onco-Hematology
Senior Consultant in Hematology
Department of Hematology
Hospital Universitario Vall d'Hebron
Barcelona, Spain

Ana Marin-Niebla, MD, PhD, has no relevant financial relationships to disclose.

Guilherme Perini, MD

Medical Hematologist
Department of Hematology
Hospital Israelita Albert Einstein
Sao Paulo, Brazil

Guilherme Perini, MD: consultant/advisor/speaker: AstraZeneca, Janssen, Merck, Takeda.

Max Topp, MD

Professor
Head of Hematology
Department of Hematology
Universitätsklinikum Würzburg
Würzburg, Germany

Max Topp, MD: consultant/advisor/speaker: AstraZeneca, Bristol-Myers Squibb, Janssen, Kite, Roche.